Cargando…

Hyperthermia (42°C) as an Adjuvant to Radiotherapy and Chemotherapy in the Treatment of the Allogeneic VX2 Carcinoma in the Rabbit

As assessed by decrease in tumour volume and inhibition of tumour cell respiration and glycolysis, hyperthermia (intra-tumour temperature 42°C for one hour) potentiated the destructive effect of radiotherapy (1000 rad) on the allogeneic VX2 carcinoma in the hind limb of rabbits, and chemotherapy (me...

Descripción completa

Detalles Bibliográficos
Autores principales: Muckle, D. S., Dickson, J. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1973
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008781/
https://www.ncbi.nlm.nih.gov/pubmed/4701703
_version_ 1782135985549606912
author Muckle, D. S.
Dickson, J. A.
author_facet Muckle, D. S.
Dickson, J. A.
author_sort Muckle, D. S.
collection PubMed
description As assessed by decrease in tumour volume and inhibition of tumour cell respiration and glycolysis, hyperthermia (intra-tumour temperature 42°C for one hour) potentiated the destructive effect of radiotherapy (1000 rad) on the allogeneic VX2 carcinoma in the hind limb of rabbits, and chemotherapy (methotrexate) produced a similar potentiation of irradiation. The resulting regression of the primary tumour in each case after dual therapy was comparable to that occurring after 3 applications of local hyperthermia, which has been shown to cure 50% of animals with this carcinoma. Combination therapy did not increase the survival time of the rabbits, however, all of which had lung and lymph node metastases at autopsy. The results focus attention on the relationship between a primary tumour and its metastases. The histological picture and the animal survival data suggest that the mechanism of tumour cell death and resorption of necrotic material following treatment may be important in enabling the host to deal with metastatic cells. After combination therapy, many metabolically and mitotically active cancer cells remained in the tumour mass, and the incomplete destruction of the primary tumour may have left the host with a burden of tumour cells too large to be destroyed by the immune system.
format Text
id pubmed-2008781
institution National Center for Biotechnology Information
language English
publishDate 1973
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20087812009-09-10 Hyperthermia (42°C) as an Adjuvant to Radiotherapy and Chemotherapy in the Treatment of the Allogeneic VX2 Carcinoma in the Rabbit Muckle, D. S. Dickson, J. A. Br J Cancer Articles As assessed by decrease in tumour volume and inhibition of tumour cell respiration and glycolysis, hyperthermia (intra-tumour temperature 42°C for one hour) potentiated the destructive effect of radiotherapy (1000 rad) on the allogeneic VX2 carcinoma in the hind limb of rabbits, and chemotherapy (methotrexate) produced a similar potentiation of irradiation. The resulting regression of the primary tumour in each case after dual therapy was comparable to that occurring after 3 applications of local hyperthermia, which has been shown to cure 50% of animals with this carcinoma. Combination therapy did not increase the survival time of the rabbits, however, all of which had lung and lymph node metastases at autopsy. The results focus attention on the relationship between a primary tumour and its metastases. The histological picture and the animal survival data suggest that the mechanism of tumour cell death and resorption of necrotic material following treatment may be important in enabling the host to deal with metastatic cells. After combination therapy, many metabolically and mitotically active cancer cells remained in the tumour mass, and the incomplete destruction of the primary tumour may have left the host with a burden of tumour cells too large to be destroyed by the immune system. Nature Publishing Group 1973-04 /pmc/articles/PMC2008781/ /pubmed/4701703 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Articles
Muckle, D. S.
Dickson, J. A.
Hyperthermia (42°C) as an Adjuvant to Radiotherapy and Chemotherapy in the Treatment of the Allogeneic VX2 Carcinoma in the Rabbit
title Hyperthermia (42°C) as an Adjuvant to Radiotherapy and Chemotherapy in the Treatment of the Allogeneic VX2 Carcinoma in the Rabbit
title_full Hyperthermia (42°C) as an Adjuvant to Radiotherapy and Chemotherapy in the Treatment of the Allogeneic VX2 Carcinoma in the Rabbit
title_fullStr Hyperthermia (42°C) as an Adjuvant to Radiotherapy and Chemotherapy in the Treatment of the Allogeneic VX2 Carcinoma in the Rabbit
title_full_unstemmed Hyperthermia (42°C) as an Adjuvant to Radiotherapy and Chemotherapy in the Treatment of the Allogeneic VX2 Carcinoma in the Rabbit
title_short Hyperthermia (42°C) as an Adjuvant to Radiotherapy and Chemotherapy in the Treatment of the Allogeneic VX2 Carcinoma in the Rabbit
title_sort hyperthermia (42°c) as an adjuvant to radiotherapy and chemotherapy in the treatment of the allogeneic vx2 carcinoma in the rabbit
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008781/
https://www.ncbi.nlm.nih.gov/pubmed/4701703
work_keys_str_mv AT muckleds hyperthermia42casanadjuvanttoradiotherapyandchemotherapyinthetreatmentoftheallogeneicvx2carcinomaintherabbit
AT dicksonja hyperthermia42casanadjuvanttoradiotherapyandchemotherapyinthetreatmentoftheallogeneicvx2carcinomaintherabbit